Abstract
Portugal introduced (2+1) conjugate Meningococcal group C vaccine in 2006 with high coverage catch up to 18 years and has given only 1 dose at 1 year since 2012. Among 601 student oropharyngeal swabs, meningococcal carriage rate was 13.3% (A-0%, B-5.3%, C-0.3%, W-0.2%, X-0.2% and Y-1.7%). C and W strains were of potentially disease-causing clonal complexes (cc) but not the hyperinvasive cc11.
| Original language | English |
|---|---|
| Pages (from-to) | 1267-1269 |
| Number of pages | 3 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 34 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Groups and Themes
- Bristol BioDesign Institute
Keywords
- Adult
- Cross-Sectional Studies
- Carrier State
- Portugal
- synthetic biology
- Humans
- Oropharynx
- Young Adult
- Male
- Adolescent
- Female
- Meningococcal Infections
- Meningococcal Vaccines
- Neisseria meningitidis
- Mass Vaccination
Fingerprint
Dive into the research topics of 'Oropharyngeal Carriage of Meningococcus in Portugal by Group and Clonal Complex 6 Years After Adolescent Vaccine Campaign'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver